Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Utah Medical Products (UTMD) Income from Continuing Operations (2016 - 2025)

Utah Medical Products has reported Income from Continuing Operations over the past 16 years, most recently at 9232000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 9232000.0 for Q4 2025, down 1454.21% from a year ago — trailing twelve months through Dec 2025 was 512000.0 (down 104.93% YoY), and the annual figure for FY2025 was 512000.0, down 104.93%.
  • Income from Continuing Operations for Q4 2025 was 9232000.0 at Utah Medical Products, down from 2631000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for UTMD hit a ceiling of 4280000.0 in Q3 2022 and a floor of 9232000.0 in Q4 2025.
  • Median Income from Continuing Operations over the past 5 years was 3439500.0 (2021), compared with a mean of 1550950.0.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 160.93% in 2021 and later crashed 1454.21% in 2025.
  • Utah Medical Products' Income from Continuing Operations stood at 2635000.0 in 2021, then plummeted by 37.72% to 3629000.0 in 2022, then crashed by 106.81% to 7505000.0 in 2023, then skyrocketed by 92.09% to 594000.0 in 2024, then crashed by 1454.21% to 9232000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 9232000.0 (Q4 2025), 2631000.0 (Q3 2025), and 3048000.0 (Q2 2025) per Business Quant data.